Eosinophilic asthma (also known as e-asthma or eos asthma) is a severe form of asthma that causes high levels of eosinophils in the lung tissue, blood, and mucus. Eosinophils are a type of immune ...

Eosinophilic asthma is a severe form of asthma caused by excess amounts of white blood cells that cause inflammation in the respiratory system. It’s rare and difficult to treat, and requires ...

Eosinophilic asthma is a more severe subtype of asthma. Treatment options include inhaled and oral corticosteroids, leukotriene modifiers, and biologics. Eosinophilic asthma is a subtype of asthma ...

Are you stuck in a cycle of asthma attacks? You may have eosinophilic asthma. Find out what it is and what you can do to break the cycle.

Interestingly, around 50% of patients with asthma also have a high number of circulating eosinophils. Patients with eosinophilic asthma tend to have more severe disease, and more frequent asthma ...

Eosinophilic asthma (e-asthma) is a rare form of the breathing disease that can be very hard to treat successfully. That can put you in a frustrating cycle of asthma attacks. People with e-asthma ...

Eosinophilic esophagitis (EoE) is a chronic esophageal inflammatory disease of undetermined pathophysiology that results in dense mucosal eosinophilia and esophageal dysfunction. In childhood ...

The European Medicines Agency will review GSK's request to approve its asthma drug Nucala as an additional treatment for ...

Remission persisted through 104 weeks for most patients with eosinophilic granulomatosis with polyangiitis who used ...

A Prescription Drug User Fee Act target date of December 16, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for review the Biologics License ...

AstraZeneca is hopping on the pickleball craze for the latest iteration of its Stepping Back Out campaign for asthma treatment Fasenra.